AD/PD™ 2027: ADVANCES IN SCIENCE & THERAPY, Organized by Kenes Group, Unveils Scientific Program Advancing Early Detection, Disease Mechanisms and Novel Therapies in Alzheimer's, Parkinson's and Related Diseases
120-session hybrid conference in Barcelona will bring together leading researchers and clinicians to explore biomarkers, disease mechanisms and novel therapeutic strategies. GENEVA, Nov. 9, 2026 /PRNewswire/ -- AD/PD™, the International Conference on Alzheimer's and Parkinson's Diseases...
Covered in this story
Call it yourself
No calls on $NOV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on NOV →Dalsna Finance is currently tracking 104 stories mentioning NOV, the earliest published 7 Oct 2025.
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.